IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

about

Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.

P2860

Q27013679-3C29F8BD-1859-4F6A-B4DA-4F9C85062429 Q35710332-4C6741A0-4EAE-490C-9C53-D9198C4FDDED

P2860

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

Item

http://www.wikidata.org/entity/Q54530047

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@en

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@nl

type

Item

label

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@en

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@nl

prefLabel

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@en

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@nl

P1476

IL-15 augments antitumoral act ...... onal antigen-presenting cells.

@en

P2093

Arjen Sloots

http://www.w3.org/2001/XMLSchema#string

Björn-Philipp Kloke

http://www.w3.org/2001/XMLSchema#string

Ute E Burkhardt

http://www.w3.org/2001/XMLSchema#string

Vera Jakobi

http://www.w3.org/2001/XMLSchema#string

Wei-Zen Wei

http://www.w3.org/2001/XMLSchema#string

Winfried S Wels

http://www.w3.org/2001/XMLSchema#string

P2860

NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

ERBB receptors and cancer: the complexity of targeted inhibitors

Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.

Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy

Designing vaccines based on biology of human dendritic cell subsets

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

P2888

s00262-012-1215-7

P304

1473-1484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-012-1215-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Federica Cavallo

P577

2012-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221829337

http://www.w3.org/2001/XMLSchema#string

P698

22331080

http://www.w3.org/2001/XMLSchema#string

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

about

P2860

P2860

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698